Birth Defect clinical trials at University of California Health
2 in progress, 1 open to eligible people
Hydrops: Diagnosing & Redefining Outcomes With Precision Study
open to eligible people ages 18-55
This is a multi-center, prospective study designed to investigate the genetic etiologies of non-immune hydrops fetalis (NIHF) and other birth defects. In the setting of NIHF, at least half of prenatally diagnosed cases remain of unknown etiology after standard work up, and a substantial proportion of other birth defects remain of unknown etiology as well. The investigators are performing trio exome sequencing (ES) for the fetus or neonate (meaning that samples are collected from the fetus or neonate as well each each biological parent for reference) to investigate the underlying genetic etiology.
at UCSF
Clinical Utility of Pediatric Whole Exome Sequencing
Sorry, in progress, not accepting new patients
The investigator aims to examine the clinical utility of WES, including assessment of a variety of clinical outcomes in undiagnosed pediatric cases.
at UCSF
Last updated: